Global Transmucosal Drug Delivery Market Insights and Forecast to 2031

Report ID: 1564453 | Published Date: Sep 2024 | No. of Page: 127 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Passive Transdermal Drug Delivery
        1.2.3 Active Transdermal Drug Delivery
    1.3 Market by Application
        1.3.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Transmucosal Drug Delivery Market Perspective (2017-2028)
    2.2 Transmucosal Drug Delivery Growth Trends by Region
        2.2.1 Transmucosal Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Transmucosal Drug Delivery Historic Market Size by Region (2017-2022)
        2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Region (2023-2028)
    2.3 Transmucosal Drug Delivery Market Dynamics
        2.3.1 Transmucosal Drug Delivery Industry Trends
        2.3.2 Transmucosal Drug Delivery Market Drivers
        2.3.3 Transmucosal Drug Delivery Market Challenges
        2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Transmucosal Drug Delivery Players by Revenue
        3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2017-2022)
        3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2017-2022)
    3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
    3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
        3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2021
    3.5 Transmucosal Drug Delivery Key Players Head office and Area Served
    3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
    3.7 Date of Enter into Transmucosal Drug Delivery Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
    4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2017-2022)
    4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Transmucosal Drug Delivery Breakdown Data by Application
    5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2017-2022)
    5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Transmucosal Drug Delivery Market Size (2017-2028)
    6.2 North America Transmucosal Drug Delivery Market Size by Type
        6.2.1 North America Transmucosal Drug Delivery Market Size by Type (2017-2022)
        6.2.2 North America Transmucosal Drug Delivery Market Size by Type (2023-2028)
        6.2.3 North America Transmucosal Drug Delivery Market Share by Type (2017-2028)
    6.3 North America Transmucosal Drug Delivery Market Size by Application
        6.3.1 North America Transmucosal Drug Delivery Market Size by Application (2017-2022)
        6.3.2 North America Transmucosal Drug Delivery Market Size by Application (2023-2028)
        6.3.3 North America Transmucosal Drug Delivery Market Share by Application (2017-2028)
    6.4 North America Transmucosal Drug Delivery Market Size by Country
        6.4.1 North America Transmucosal Drug Delivery Market Size by Country (2017-2022)
        6.4.2 North America Transmucosal Drug Delivery Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Transmucosal Drug Delivery Market Size (2017-2028)
    7.2 Europe Transmucosal Drug Delivery Market Size by Type
        7.2.1 Europe Transmucosal Drug Delivery Market Size by Type (2017-2022)
        7.2.2 Europe Transmucosal Drug Delivery Market Size by Type (2023-2028)
        7.2.3 Europe Transmucosal Drug Delivery Market Share by Type (2017-2028)
    7.3 Europe Transmucosal Drug Delivery Market Size by Application
        7.3.1 Europe Transmucosal Drug Delivery Market Size by Application (2017-2022)
        7.3.2 Europe Transmucosal Drug Delivery Market Size by Application (2023-2028)
        7.3.3 Europe Transmucosal Drug Delivery Market Share by Application (2017-2028)
    7.4 Europe Transmucosal Drug Delivery Market Size by Country
        7.4.1 Europe Transmucosal Drug Delivery Market Size by Country (2017-2022)
        7.4.2 Europe Transmucosal Drug Delivery Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2017-2028)
    8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type
        8.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Transmucosal Drug Delivery Market Share by Type (2017-2028)
    8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application
        8.3.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Transmucosal Drug Delivery Market Share by Application (2017-2028)
    8.4 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
        8.4.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Transmucosal Drug Delivery Market Size (2017-2028)
    9.2 Latin America Transmucosal Drug Delivery Market Size by Type
        9.2.1 Latin America Transmucosal Drug Delivery Market Size by Type (2017-2022)
        9.2.2 Latin America Transmucosal Drug Delivery Market Size by Type (2023-2028)
        9.2.3 Latin America Transmucosal Drug Delivery Market Share by Type (2017-2028)
    9.3 Latin America Transmucosal Drug Delivery Market Size by Application
        9.3.1 Latin America Transmucosal Drug Delivery Market Size by Application (2017-2022)
        9.3.2 Latin America Transmucosal Drug Delivery Market Size by Application (2023-2028)
        9.3.3 Latin America Transmucosal Drug Delivery Market Share by Application (2017-2028)
    9.4 Latin America Transmucosal Drug Delivery Market Size by Country
        9.4.1 Latin America Transmucosal Drug Delivery Market Size by Country (2017-2022)
        9.4.2 Latin America Transmucosal Drug Delivery Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2017-2028)
    10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type
        10.2.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Transmucosal Drug Delivery Market Share by Type (2017-2028)
    10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application
        10.3.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Transmucosal Drug Delivery Market Share by Application (2017-2028)
    10.4 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
        10.4.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 3M Pharmaceuticals
        11.1.1 3M Pharmaceuticals Company Details
        11.1.2 3M Pharmaceuticals Business Overview
        11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
        11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.1.5 3M Pharmaceuticals Recent Developments
    11.2 Acrux Limited
        11.2.1 Acrux Limited Company Details
        11.2.2 Acrux Limited Business Overview
        11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
        11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.2.5 Acrux Limited Recent Developments
    11.3 ALZA Corporation
        11.3.1 ALZA Corporation Company Details
        11.3.2 ALZA Corporation Business Overview
        11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
        11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.3.5 ALZA Corporation Recent Developments
    11.4 Antares Pharma, Inc.
        11.4.1 Antares Pharma, Inc. Company Details
        11.4.2 Antares Pharma, Inc. Business Overview
        11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
        11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.4.5 Antares Pharma, Inc. Recent Developments
    11.5 Apricus BioSciences, Inc
        11.5.1 Apricus BioSciences, Inc Company Details
        11.5.2 Apricus BioSciences, Inc Business Overview
        11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
        11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.5.5 Apricus BioSciences, Inc Recent Developments
    11.6 Aveva Drug Delivery Systems
        11.6.1 Aveva Drug Delivery Systems Company Details
        11.6.2 Aveva Drug Delivery Systems Business Overview
        11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
        11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.6.5 Aveva Drug Delivery Systems Recent Developments
    11.7 Corium International, Inc
        11.7.1 Corium International, Inc Company Details
        11.7.2 Corium International, Inc Business Overview
        11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
        11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.7.5 Corium International, Inc Recent Developments
    11.8 DURECT Corporation
        11.8.1 DURECT Corporation Company Details
        11.8.2 DURECT Corporation Business Overview
        11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
        11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.8.5 DURECT Corporation Recent Developments
    11.9 Generex Biotechnology Corporation
        11.9.1 Generex Biotechnology Corporation Company Details
        11.9.2 Generex Biotechnology Corporation Business Overview
        11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
        11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.9.5 Generex Biotechnology Corporation Recent Developments
    11.10 Inovio Pharmaceuticals, Inc.
        11.10.1 Inovio Pharmaceuticals, Inc. Company Details
        11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
        11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
        11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.10.5 Inovio Pharmaceuticals, Inc. Recent Developments
    11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
        11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
        11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
        11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
        11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
    11.12 MedPharm LTD
        11.12.1 MedPharm LTD Company Details
        11.12.2 MedPharm LTD Business Overview
        11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
        11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.12.5 MedPharm LTD Recent Developments
    11.13 Mylan, Inc.
        11.13.1 Mylan, Inc. Company Details
        11.13.2 Mylan, Inc. Business Overview
        11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
        11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.13.5 Mylan, Inc. Recent Developments
    11.14 Nemaura Pharma Ltd
        11.14.1 Nemaura Pharma Ltd Company Details
        11.14.2 Nemaura Pharma Ltd Business Overview
        11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
        11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.14.5 Nemaura Pharma Ltd Recent Developments
    11.15 Nitto Denko Corporation
        11.15.1 Nitto Denko Corporation Company Details
        11.15.2 Nitto Denko Corporation Business Overview
        11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
        11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.15.5 Nitto Denko Corporation Recent Developments
    11.16 Noven Pharmaceuticals, Inc.
        11.16.1 Noven Pharmaceuticals, Inc. Company Details
        11.16.2 Noven Pharmaceuticals, Inc. Business Overview
        11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
        11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.16.5 Noven Pharmaceuticals, Inc. Recent Developments
    11.17 Pantec Biosolutions AG
        11.17.1 Pantec Biosolutions AG Company Details
        11.17.2 Pantec Biosolutions AG Business Overview
        11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
        11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.17.5 Pantec Biosolutions AG Recent Developments
    11.18 Tapemark
        11.18.1 Tapemark Company Details
        11.18.2 Tapemark Business Overview
        11.18.3 Tapemark Transmucosal Drug Delivery Introduction
        11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.18.5 Tapemark Recent Developments
    11.19 tesa Labtec GmbH
        11.19.1 tesa Labtec GmbH Company Details
        11.19.2 tesa Labtec GmbH Business Overview
        11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
        11.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.19.5 tesa Labtec GmbH Recent Developments
    11.20 TEVA Pharmaceutical Industries Ltd.
        11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
        11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
        11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
        11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments
    11.21 Zosano Pharma
        11.21.1 Zosano Pharma Company Details
        11.21.2 Zosano Pharma Business Overview
        11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
        11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022)
        11.21.5 Zosano Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Passive Transdermal Drug Delivery
    Table 3. Key Players of Active Transdermal Drug Delivery
    Table 4. Global Transmucosal Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Transmucosal Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Transmucosal Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Transmucosal Drug Delivery Market Share by Region (2017-2022)
    Table 8. Global Transmucosal Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Transmucosal Drug Delivery Market Share by Region (2023-2028)
    Table 10. Transmucosal Drug Delivery Market Trends
    Table 11. Transmucosal Drug Delivery Market Drivers
    Table 12. Transmucosal Drug Delivery Market Challenges
    Table 13. Transmucosal Drug Delivery Market Restraints
    Table 14. Global Transmucosal Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Transmucosal Drug Delivery Revenue Share by Players (2017-2022)
    Table 16. Global Top Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
    Table 17. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Transmucosal Drug Delivery Product Solution and Service
    Table 21. Date of Enter into Transmucosal Drug Delivery Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Type (2017-2022)
    Table 25. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Transmucosal Drug Delivery Revenue Market Share by Type (2023-2028)
    Table 27. Global Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Transmucosal Drug Delivery Revenue Share by Application (2017-2022)
    Table 29. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Transmucosal Drug Delivery Revenue Share by Application (2023-2028)
    Table 31. North America Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Transmucosal Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Transmucosal Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Transmucosal Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Transmucosal Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Transmucosal Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Transmucosal Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Transmucosal Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Transmucosal Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Transmucosal Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Transmucosal Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Transmucosal Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Transmucosal Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 61. 3M Pharmaceuticals Company Details
    Table 62. 3M Pharmaceuticals Business Overview
    Table 63. 3M Pharmaceuticals Transmucosal Drug Delivery Product
    Table 64. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 65. 3M Pharmaceuticals Recent Developments
    Table 66. Acrux Limited Company Details
    Table 67. Acrux Limited Business Overview
    Table 68. Acrux Limited Transmucosal Drug Delivery Product
    Table 69. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 70. Acrux Limited Recent Developments
    Table 71. ALZA Corporation Company Details
    Table 72. ALZA Corporation Business Overview
    Table 73. ALZA Corporation Transmucosal Drug Delivery Product
    Table 74. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 75. ALZA Corporation Recent Developments
    Table 76. Antares Pharma, Inc. Company Details
    Table 77. Antares Pharma, Inc. Business Overview
    Table 78. Antares Pharma, Inc. Transmucosal Drug Delivery Product
    Table 79. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 80. Antares Pharma, Inc. Recent Developments
    Table 81. Apricus BioSciences, Inc Company Details
    Table 82. Apricus BioSciences, Inc Business Overview
    Table 83. Apricus BioSciences, Inc Transmucosal Drug Delivery Product
    Table 84. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 85. Apricus BioSciences, Inc Recent Developments
    Table 86. Aveva Drug Delivery Systems Company Details
    Table 87. Aveva Drug Delivery Systems Business Overview
    Table 88. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product
    Table 89. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 90. Aveva Drug Delivery Systems Recent Developments
    Table 91. Corium International, Inc Company Details
    Table 92. Corium International, Inc Business Overview
    Table 93. Corium International, Inc Transmucosal Drug Delivery Product
    Table 94. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 95. Corium International, Inc Recent Developments
    Table 96. DURECT Corporation Company Details
    Table 97. DURECT Corporation Business Overview
    Table 98. DURECT Corporation Transmucosal Drug Delivery Product
    Table 99. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 100. DURECT Corporation Recent Developments
    Table 101. Generex Biotechnology Corporation Company Details
    Table 102. Generex Biotechnology Corporation Business Overview
    Table 103. Generex Biotechnology Corporation Transmucosal Drug Delivery Product
    Table 104. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 105. Generex Biotechnology Corporation Recent Developments
    Table 106. Inovio Pharmaceuticals, Inc. Company Details
    Table 107. Inovio Pharmaceuticals, Inc. Business Overview
    Table 108. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
    Table 109. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 110. Inovio Pharmaceuticals, Inc. Recent Developments
    Table 111. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
    Table 112. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
    Table 113. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product
    Table 114. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 115. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
    Table 116. MedPharm LTD Company Details
    Table 117. MedPharm LTD Business Overview
    Table 118. MedPharm LTD Transmucosal Drug Delivery Product
    Table 119. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 120. MedPharm LTD Recent Developments
    Table 121. Mylan, Inc. Company Details
    Table 122. Mylan, Inc. Business Overview
    Table 123. Mylan, Inc. Transmucosal Drug Delivery Product
    Table 124. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 125. Mylan, Inc. Recent Developments
    Table 126. Nemaura Pharma Ltd Company Details
    Table 127. Nemaura Pharma Ltd Business Overview
    Table 128. Nemaura Pharma Ltd Transmucosal Drug Delivery Product
    Table 129. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 130. Nemaura Pharma Ltd Recent Developments
    Table 131. Nitto Denko Corporation Company Details
    Table 132. Nitto Denko Corporation Business Overview
    Table 133. Nitto Denko Corporation Transmucosal Drug Delivery Product
    Table 134. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 135. Nitto Denko Corporation Recent Developments
    Table 136. Noven Pharmaceuticals, Inc. Company Details
    Table 137. Noven Pharmaceuticals, Inc. Business Overview
    Table 138. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
    Table 139. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 140. Noven Pharmaceuticals, Inc. Recent Developments
    Table 141. Pantec Biosolutions AG Company Details
    Table 142. Pantec Biosolutions AG Business Overview
    Table 143. Pantec Biosolutions AG Transmucosal Drug Delivery Product
    Table 144. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 145. Pantec Biosolutions AG Recent Developments
    Table 146. Tapemark Company Details
    Table 147. Tapemark Business Overview
    Table 148. Tapemark Transmucosal Drug Delivery Product
    Table 149. Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 150. Tapemark Recent Developments
    Table 151. tesa Labtec GmbH Company Details
    Table 152. tesa Labtec GmbH Business Overview
    Table 153. tesa Labtec GmbH Transmucosal Drug Delivery Product
    Table 154. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 155. tesa Labtec GmbH Recent Developments
    Table 156. TEVA Pharmaceutical Industries Ltd. Company Details
    Table 157. TEVA Pharmaceutical Industries Ltd. Business Overview
    Table 158. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product
    Table 159. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 160. TEVA Pharmaceutical Industries Ltd. Recent Developments
    Table 161. Zosano Pharma Company Details
    Table 162. Zosano Pharma Business Overview
    Table 163. Zosano Pharma Transmucosal Drug Delivery Product
    Table 164. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
    Table 165. Zosano Pharma Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2021 VS 2028
    Figure 2. Passive Transdermal Drug Delivery Features
    Figure 3. Active Transdermal Drug Delivery Features
    Figure 4. Global Transmucosal Drug Delivery Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Transmucosal Drug Delivery Report Years Considered
    Figure 9. Global Transmucosal Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Transmucosal Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Transmucosal Drug Delivery Market Share by Region: 2021 VS 2028
    Figure 12. Global Transmucosal Drug Delivery Market Share by Players in 2021
    Figure 13. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2021
    Figure 15. North America Transmucosal Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Transmucosal Drug Delivery Market Size Market Share by Type (2017-2028)
    Figure 17. North America Transmucosal Drug Delivery Market Size Market Share by Application (2017-2028)
    Figure 18. North America Transmucosal Drug Delivery Market Size Share by Country (2017-2028)
    Figure 19. United States Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Transmucosal Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Transmucosal Drug Delivery Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Transmucosal Drug Delivery Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Transmucosal Drug Delivery Market Size Share by Country (2017-2028)
    Figure 25. Germany Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Transmucosal Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Transmucosal Drug Delivery Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Transmucosal Drug Delivery Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Transmucosal Drug Delivery Market Size Share by Region (2017-2028)
    Figure 35. China Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Transmucosal Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Transmucosal Drug Delivery Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Transmucosal Drug Delivery Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Transmucosal Drug Delivery Market Size Share by Country (2017-2028)
    Figure 45. Mexico Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Transmucosal Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Transmucosal Drug Delivery Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Transmucosal Drug Delivery Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Transmucosal Drug Delivery Market Size Share by Country (2017-2028)
    Figure 51. Turkey Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. 3M Pharmaceuticals Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 55. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 56. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 57. Antares Pharma, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 58. Apricus BioSciences, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 59. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 60. Corium International, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 61. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 62. Generex Biotechnology Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 63. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 64. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 65. MedPharm LTD Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 66. Mylan, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 67. Nemaura Pharma Ltd Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 68. Nitto Denko Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 69. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 70. Pantec Biosolutions AG Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 71. Tapemark Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 72. tesa Labtec GmbH Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 73. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 74. Zosano Pharma Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Frequently Asked Questions
Transmucosal Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transmucosal Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transmucosal Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biometrics Banking

Biometrics Banking market is segmented by players, region (country), by Type and by Application.  ... Read More